Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects
Lung cancer, the second most commonly diagnosed cancer, is the major cause of fatalities worldwide for both men and women, with an estimated 2.2 million new incidences and 1.8 million deaths, according to GLOBOCAN 2020. Although various risk factors for lung cancer pathogenesis have been reported, c...
Saved in:
Main Authors: | Shailendra Kumar Gangwar (Author), Aviral Kumar (Author), Kenneth Chun-Hong Yap (Author), Sandra Jose (Author), Dey Parama (Author), Gautam Sethi (Author), Alan Prem Kumar (Author), Ajaikumar B. Kunnumakkara (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The promising potential of piperlongumine as an emerging therapeutics for cancer
by: Dey Parama, et al.
Published: (2021) -
Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
by: Uzini Devi Daimary, et al.
Published: (2021) -
Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
by: Sosmitha Girisa, et al.
Published: (2020) -
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
by: Aviral Kumar, et al.
Published: (2024) -
Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3,5-dihydroxy-4',7-dimethoxyflavone isolated from the leaves of Alpinia nigra
by: Manish Kumar Gupta, et al.
Published: (2021)